APELLIS PHARMACEUTICALS, INC.

APLS · NASDAQ

Pharmaceutical Preparation Manufacturing · United States

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.

Market Data

Price $40.96 +0.01 (+0.02%)

Market Cap$5.24B

P/E Ratio234.16

EPS$—

52W High$41.00

52W Low$16.10

Beta-0.24

Data from Finnhub · Updated May 1, 2026